CHICAGO, May 7 /PRNewswire-FirstCall/ -- The Female Health Company today announced that it will host an investor conference call to discuss its operating results for the second quarter of FY2008 at 11:00 a.m. Eastern Time (EDT) on Wednesday, May 14, 2008. The Company plans to report its second quarter FY2008 operating results earlier the same day.
Shareholders and other interested parties may participate in the conference call by dialing 800-860-2442 (international participants dial 412-858-4600) and asking to be connected to the Female Health Company Conference Call, a few minutes before 11:00 a.m. EDT on May 14, 2008. A replay of the call will be available one hour after the call through 5:00 pm on May 28, 2008 by dialing 877-344-7529 (international callers dial 412-317-0088) and entering the conference ID 418836.
About The Female Health Company
The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC Female Condom(R), which is primarily distributed by public health organizations and donor groups in over 90 developing countries around the world. World-wide, the Female Condom is available in various programs in 108 countries. The Company owns certain worldwide rights to the FC Female Condom(R), including patents that have been issued in the United States, United Kingdom, Japan, France, Italy, Germany, Spain, the European Patent Convention, the People’s Republic of China, Canada, South Korea and Australia. FC Female Condom(R) is the only available FDA-approved product controlled by a woman that offers dual protection against sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy.
“Safe Harbor” statement under the Private Securities Litigation Reform Action of 1995: The statements in this release which are not historical fact are forward-looking statements based upon the Company’s current plans and strategies, and reflect the Company’s current assessment of the risks and uncertainties related to its business, including such things as product demand and market acceptance; the economic and business environment and the impact of government pressures; currency risks; capacity; efficiency and supply constraints; and other risks detailed in the Company’s press releases, shareholder communications and Securities and Exchange Commission filings. Actual events affecting the Company and the impact of such events on the Company’s operations may vary from those currently anticipated.
For more information about the Female Health Company, visit the Company’s web
CONTACT: William R. Gargiulo, Jr., +1-231-526-1244, or Donna Felch, CFO,
+1-312-595-9123, both of The Female Health Company
Web site: http://www.femalehealth.com/
http://www.femalecondom.org/
